The issue of administering 'additional' dose of COVID-19 vaccine to immunocompromised individuals will be deliberated upon in the meeting of the National Technical Advisory Group on Immunisation......
Pfizer is in discussions with the Indian government for an expedited approval pathway to make Pfizer-BioNTech vaccine available in the country, its chief Albert Bourla said on Monday, while stating......
Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending......
India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the......
India on Saturday received the first consignment of 1.5 lakh doses of Sputnik V COVID-19 vaccine from Russia as the country embarked on the third phase of the vaccination drive against the......
Indian drug firms get a shot in the arm in the $12 bn Australian drug market as the Therapeutic Goods Administration (TGA), Australia agrees to accelerate the drug approval process in that country......
Ranbaxy Ltd has been asked by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the largest drug regulator in Europe, to recall its drugs used to treat skin infections.Ranbaxy (UK)......
In its first acquisition in Europe, Aurobindo Pharma Ltd today said it has acquired UK-based Milpharm Ltd, in an all cash deal, from Whyte Group and Iracot Ltd.Part of the Foreign Currency......
Will Wockhardt be the next Ranbaxy? This is being asked in the backdrop of the company being under the scrutiny of both the American and British drug regulators.First came an import alert from the......
Orchid Chemicals & Pharmaceuticals said on Thursday that major stakeholder Solrex Pharmaceuticals is linked to Ranbaxy Laboratories, but it did not expect a takeover attempt. Privately held Solrex......